Metronidazole Stock Solution Preparation & Handling Protocol

Metronidazole is a nitroimidazole-class antibiotic and antiprotozoal agent widely used in research to selectively deplete anaerobic bacteria, study gut microbiome dynamics, and serve as a positive control in antimicrobial susceptibility assays.

Chemical Name

2-(2-Methyl-5-nitroimidazol-1-yl)ethanol

Molecular Formula

C₆H₉N₃O₃

Molecular Weight

171.16 g/mol

CAS Number

443-48-1

Solubility

Soluble in DMSO (~50 mg/mL) and water (~10 mg/mL at 25 °C); sparingly soluble in ethanol

Storage

Store at room temperature, protected from light, in a tightly sealed container

Appearance

White to pale yellow crystalline powder

Materials and Reagents

Before beginning, ensure the following materials are available:

• Metronidazole (Aladdin Scientific, SKU: M109874)
• Appropriate solvent: ultrapure water, DMSO, or PBS (pH 7.4) depending on intended application
• Analytical balance (readability ≤ 0.1 mg)
• Volumetric flasks or microcentrifuge tubes (amber or foil-wrapped to protect from light)
• 0.22 µm sterile syringe filter (for cell culture applications)
• Personal protective equipment (lab coat, nitrile gloves, eye protection)

Note: Metronidazole is light-sensitive; all preparation and storage vessels should be protected from direct light exposure.

Stock Solution Preparation

Follow these steps to prepare a metronidazole stock solution suitable for most research applications:

1. Calculate the required mass: Determine the desired stock concentration (commonly 50–100 mM) and volume, then calculate the required mass using: mass (mg) = concentration (mM) × volume (mL) × MW (g/mol) ÷ 1000. For a 50 mM solution in 10 mL DMSO: mass = 50 × 10 × 171.16 ÷ 1000 = 85.6 mg.
2. Weigh the compound: Tare an amber glass vial on an analytical balance and accurately weigh the calculated mass of metronidazole powder.
3. Add solvent: Add approximately 80% of the target volume of solvent (DMSO for high-concentration stocks; ultrapure water or PBS for aqueous stocks up to ~10 mg/mL). Vortex gently for 30–60 seconds until fully dissolved.
4. Adjust to final volume: Transfer to a volumetric flask and bring to the final volume with the same solvent. Mix by inversion.
5. Filter-sterilize (cell culture use): Pass the solution through a 0.22 µm syringe filter into a sterile amber collection tube.
6. Verify dissolution: Visually confirm the solution is clear and free of particulates before proceeding.

Tip: If precipitate forms when diluting DMSO stocks into aqueous media, warm the aqueous solution briefly to 37 °C and vortex to improve solubility, or reduce the final DMSO concentration to ≤ 0.1% (v/v) for cell-based assays.

Working Solution Preparation and Application

Metronidazole working solutions are prepared by diluting the stock into the appropriate experimental medium immediately before use.

In Vitro (Cell Culture)

• Dilute the DMSO or aqueous stock into complete culture medium to achieve the desired working concentration (typical range: 10–500 µM for cytotoxicity studies; concentrations vary widely by cell line and experimental goal).
• Final DMSO concentration must not exceed 0.1% (v/v) to avoid solvent-related cytotoxicity. Include a vehicle control at the same DMSO concentration.
• Prepare fresh working solutions on the day of the experiment when possible.

In Vivo (Animal Studies)

• For oral administration via drinking water (commonly used for gut microbiome depletion studies), dissolve metronidazole in autoclaved drinking water at the target concentration. Protect water bottles from light and replace solutions every 2–3 days.
• For injection, prepare sterile aqueous or saline solutions and filter-sterilize. Verify compatibility with the chosen vehicle and route of administration.

Always consult your institutional animal care and use guidelines before initiating in vivo studies.

Storage and Stability

Proper storage is critical to maintaining metronidazole activity and solution integrity.

• Solid powder: Store at room temperature (15–25 °C) in a tightly sealed container, protected from light and moisture. Shelf life is typically several years when stored correctly.
• DMSO stock solutions: Aliquot into single-use volumes to avoid repeated freeze-thaw cycles. Store at –20 °C, protected from light. Stable for up to 6 months under these conditions.
• Aqueous stock solutions: Prepare fresh where possible. If storage is required, store at 4 °C protected from light and use within 1 week. Do not store aqueous solutions long-term as hydrolytic degradation may occur.
• Working solutions in culture medium: Prepare fresh on the day of use; do not store.

Review_flag: Specific stability durations for DMSO and aqueous solutions should be confirmed against validated stability data; the durations stated here are general guidance based on physicochemical properties.

Safety and Handling Considerations

Metronidazole is classified as a potential mutagen and possible carcinogen (IARC Group 2B) based on animal studies. The following precautions are required in a research laboratory setting:

• Handle in a well-ventilated area or biological safety cabinet where appropriate.
• Wear appropriate PPE at all times: laboratory coat, nitrile gloves (double-gloving recommended when handling concentrated solutions), and eye protection.
• Avoid generating dust when weighing powder; consider using a balance enclosure.
• Dispose of all metronidazole-containing waste (solutions, contaminated materials) in accordance with local institutional and regulatory hazardous waste disposal guidelines.
• Refer to the Safety Data Sheet (SDS) provided by Aladdin Scientific (SKU: M109874) for complete hazard information, first aid measures, and disposal requirements.

Note: IARC Group 2B classification should be confirmed with the current SDS. Handling requirements may vary by jurisdiction.

Frequently asked questions

What is the best solvent for preparing a metronidazole stock solution?

DMSO is the preferred solvent for preparing high-concentration stock solutions (up to ~50 mg/mL), offering superior solubility compared to water (~10 mg/mL at 25 °C). For applications where DMSO is incompatible, sterile ultrapure water or PBS can be used for lower-concentration aqueous stocks. Always dilute DMSO stocks to ≤ 0.1% (v/v) final DMSO in cell-based assays.

Why must metronidazole solutions be protected from light?

Metronidazole is photosensitive and can undergo photodegradation upon prolonged exposure to light, particularly UV light, which may reduce its concentration and generate degradation products that could confound experimental results. Always store solutions in amber glassware or foil-wrapped containers and minimize light exposure during handling.

What concentrations of metronidazole are typically used in gut microbiome depletion studies?

In murine gut microbiome depletion studies, metronidazole is commonly administered via drinking water, often as part of an antibiotic cocktail. Concentrations used in the literature vary; a frequently cited range is 0.5–1 g/L in drinking water, sometimes combined with ampicillin, neomycin, and vancomycin. Researchers should consult primary literature and institutional guidelines to select an appropriate concentration for their specific experimental model.

Can metronidazole stock solutions be frozen and thawed multiple times?

Repeated freeze-thaw cycles are not recommended as they may compromise solution stability and lead to concentration variability. It is best practice to aliquot stock solutions into single-use volumes upon preparation, store aliquots at –20 °C, and thaw only the volume needed for each experiment.

Is metronidazole suitable for use in aerobic cell culture experiments?

Yes, metronidazole can be used in aerobic cell culture experiments, for example to assess cytotoxicity, study drug resistance mechanisms, or serve as a research tool compound. However, its primary antimicrobial activity is selective for anaerobic and microaerophilic organisms, as its mechanism of action requires reductive activation under low-oxygen conditions. Researchers should consider this selectivity when designing experiments with aerobic cell lines.

References

1. Edwards DI. Metronidazole. Journal of Antimicrobial Chemotherapy. 1993;31(1):9–28. doi:10.1093/jac/31.1.9
2. Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clinical Infectious Diseases. 2010;50(S1):S16–S23. doi:10.1086/647939
3. IARC Working Group. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 113. IARC; 2018.
4. Reikvam DH, Erofeev A, Sandvik A, et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLOS ONE. 2011;6(3):e17996. doi:10.1371/journal.pone.0017996

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.